Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34690
Full metadata record
DC FieldValueLanguage
dc.contributor.authorModra, Lucy J-
dc.contributor.authorHiggins, Alisa M-
dc.contributor.authorPilcher, David V-
dc.contributor.authorCheung, Ada S-
dc.contributor.authorCarpenter, Morgan N-
dc.contributor.authorBailey, Michael-
dc.contributor.authorZwickl, Sav-
dc.contributor.authorBellomo, Rinaldo-
dc.date2023-
dc.date.accessioned2024-01-02T02:01:53Z-
dc.date.available2024-01-02T02:01:53Z-
dc.date.issued2023-12-09-
dc.identifier.citationChest 2023-12-09en_US
dc.identifier.issn1931-3543-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34690-
dc.description.abstractPatient sex affects treatment and outcomes in critical illness. Previous studies of sex differences in critical illness compared female and male patients. In this study we describe the group of patients classified as a third sex admitted to intensive care units (ICUs) in Australia and New Zealand. What are the admission characteristics and outcomes of ICU patients classified as belonging to a third sex group, compared to patients classified female or male? Retrospective observational study of admissions to 200 ICUs, recorded in the Australia and New Zealand Intensive Care Society's Adult Patient Database 2018-2022. We undertook mixed effect logistic regression to compare hospital mortality across the sex groups, adjusted for illness severity, diagnosis, treatment limitation, year and hospital. We examined 892,161 admissions, of whom 525 (0.06%) were classified as third sex. Patients classified as third sex were represented across all diagnostic categories, jurisdictions, and hospital types. On average, they were younger than the groups classified as female (59.2+/-20.0 years vs 61.3+/-18.4 years, p=0.02) or male (63.2+/-16.7 years, p<0.001). Patients classified as third sex were more likely to be admitted following orthopedic surgery (10.1% third sex admissions (95% CI 7.7-13.0%) vs 6.2% female (95% CI 6.1-6.3%); 4.8% male (95% CI 4.7-4.9%)) and drug overdose (8.8% third sex admissions (95% CI 6.5-11.5%) vs 4.2% female (95% CI 4.1-4.2%); 3.1% male (95% CI 3.0-3.1%)). There was no difference in the adjusted hospital mortality of patients classified as third sex compared to the other groups. Patients classified as third sex composed a small minority of adult ICU patients. This group had a different diagnostic casemix, but similar outcomes, to the groups classified as female or male. Further characterizing a third sex group will require improved processes for recording sex and gender in health records.en_US
dc.language.isoeng-
dc.subjectcritical illnessen_US
dc.subjectgenderen_US
dc.subjectintensive care uniten_US
dc.subjectsexen_US
dc.titleEpidemiology of intensive care patients classified as a third sex in Australia and New Zealand.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleChesten_US
dc.identifier.affiliationIntensive Careen_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Monash University, Melbourne Australia; Intensive Care Unit, Alfred Health, Melbourne, Australia; The Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcome and Resource Evaluation, Camberwell Road, Camberwell, Melbourne, Australia.en_US
dc.identifier.affiliationTrans Health Research Group, Department of Medicine, The University of Melbourne, Australia.en_US
dc.identifier.affiliationThe University of Sydney School of Public Health.en_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Monash University, Melbourne Australia.en_US
dc.identifier.affiliationTrans Health Research Group, Department of Medicine, The University of Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Critical Care, University of Melbourne, Melbourne, Australia; Intensive Care Unit, Austin Health, Melbourne, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne Australia; Intensive Care Unit, Royal Melbourne Hospital, Melbourne, Australia.en_US
dc.identifier.doi10.1016/j.chest.2023.11.043en_US
dc.type.contentTexten_US
dc.identifier.pubmedid38081578-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptIntensive Care-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

42
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.